Home/Filings/4/0001140361-16-078625
4//SEC Filing

Relypsa Inc 4

Accession 0001140361-16-078625

CIK 0001416792operating

Filed

Sep 1, 8:00 PM ET

Accepted

Sep 2, 12:33 PM ET

Size

15.2 KB

Accession

0001140361-16-078625

Insider Transaction Report

Form 4
Period: 2016-09-01
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2016-09-014,5000 total
    Exercise: $17.00Exp: 2026-06-20Common Stock (4,500 underlying)
  • Disposition to Issuer

    Common Stock

    2016-09-01$32.00/sh2,250$72,0000 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2016-09-014,5000 total
    Exercise: $35.79Exp: 2025-06-03Common Stock (4,500 underlying)
  • Disposition from Tender

    Common Stock

    2016-09-01$32.00/sh2,849$91,1682,250 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2016-09-0124,6320 total
    Exercise: $11.00Exp: 2023-11-13Common Stock (24,632 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2016-09-013,8280 total
    Exercise: $23.96Exp: 2024-06-18Common Stock (3,828 underlying)
Footnotes (3)
  • [F1]Pursuant to the terms of the Agreement and Plan of Merger, dated as of July 20, 2016 (the "Merger Agreement"), by and among the Issuer, Galencia AG, a public limited company existing under the laws of Switzerland ("Parent"), and Vifor Pharma USA Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent, on September 1, 2016, shares disposed of in exchange for cash consideration of $32.00 per share, without interest, subject to any applicable withholding taxes.
  • [F2]Pursuant to the terms of the Merger Agreement, on September 1, 2016, each award of restricted stock units and stock options was cancelled in exchange for the right to receive $32.00 per share in cash less any applicable withholding taxes and in the case of stock options, less the applicable exercise price.
  • [F3]Pursuant to the terms of the Merger Agreement, on September 1, 2016, the stock option was cancelled and no cash payment was made as the exercise price exceeded $32.00 per share.

Documents

1 file

Issuer

Relypsa Inc

CIK 0001416792

Entity typeoperating

Related Parties

1
  • filerCIK 0001416792

Filing Metadata

Form type
4
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 12:33 PM ET
Size
15.2 KB